Moreover, HMGA1 silencing reduced cardiac dysfunction as evidenced by increased LVEF, FS, dp/dtmax, and dp/dtmin and a decreased Tau value in the AAV9-shHMGA1 group when compared with those in the AAV9-shRNA-DCM group (Table S2). This evidence concerns the gene HMGA1 and familial dilated cardiomyopathy.